William Blair & Company 33rd Annual Growth Stock Conference
Goldman Sachs 34th Annual Global Healthcare Conference
PLEASANTON, Calif., June 3, 2013 (GLOBE NEWSWIRE) -- ZELTIQ® Aesthetics, Inc., (Nasdaq:ZLTQ) a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Patrick F. Williams, Senior Vice President and Chief Financial Officer, is scheduled to present at the William Blair & Company 33rd Annual Growth Stock Conference at the Four Seasons Hotel in Chicago, Illinois and the Goldman Sachs 34th Annual Global Healthcare Conference at the Terranea Resort in Rancho Palos Verdes, California.
| Event: William Blair & Company 33rd Annual Growth Stock Conference |
| Date: June 11, 2013 |
| Time: 4:10 p.m. CT /5:10 p.m. ET |
| Event: Goldman Sachs 34th Annual Global Healthcare Conference |
| Date: June 12, 2013 |
| Time: 2:00 p.m. PT /5:00 p.m. ET |
An audio web cast of the Company's presentation will be available by visiting the investor relations section of ZELTIQ's web site at www.coolsculpting.com. A replay of the presentation will be available for 30 days.
About ZELTIQ® Aesthetics, Inc.
ZELTIQ is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting® System, is designed to selectively reduce stubborn fat that may not respond to diet or exercise. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed CoolSculpting to safely, noticeably and measurably reduce the fat layer.